Mark A. Meltz

Business address
C/O Audentes Therapeutics, Inc., 600 California Street, 17 Th Floor, San Francisco, CA, 94108
Top holdings (ownership)
KNTE
Get insider transactions for this reporting owner
Mark A. Meltz has filed 18 SEC EDGAR filings since 01 Apr 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 11 Jun 2025 09 Jun 2025 001-40502
3 Open Document Open Filing 11 Jun 2025 09 Jun 2025 001-40502
4 Open Document Open Filing 05 Apr 2024 03 Apr 2024 001-39743
4 Open Document Open Filing 05 Mar 2024 01 Mar 2024 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 05 Dec 2023 01 Dec 2023 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 06 Sep 2023 01 Sep 2023 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jun 2023 01 Jun 2023 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 03 Mar 2023 01 Mar 2023 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 14 Feb 2023 10 Feb 2023 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 02 Dec 2022 01 Dec 2022 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 02 Sep 2022 01 Sep 2022 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 15 Feb 2022 11 Feb 2022 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 16 Feb 2021 12 Feb 2021 001-39743
3 Open Document Open Filing FORM 3 02 Dec 2020 02 Dec 2020 001-39743
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jan 2020 15 Jan 2020 001-37833
4 Open Document Open Filing FORM 4 SUBMISSION 16 Dec 2019 12 Dec 2019 001-37833
4 Open Document Open Filing FORM 4 SUBMISSION 01 Apr 2019 28 Mar 2019 001-37833
3 Open Document Open Filing FORM 3 SUBMISSION 01 Apr 2019 28 Mar 2019 001-37833